SAGE - Sage Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart

SAGE is currently covered by 17 analysts with an average potential upside of $25.89 (33.84%) from yesterday's end of day stock price of $20.01. Sage Therapeutics activity chart has currently 243 price targets and 269 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 55.39% with an average time for these price targets to be met of 172.3 days.

Highest price target for SAGE is $53, Lowest price target is $17, average price target is $35.

Most recent stock forecast was given by BRIAN ABRAHAMS from RBC on 08-Nov-2023. First documented stock forecast 12-Aug-2014.

Currently, out of the existing stock ratings of SAGE - 25 which are a Hold (47.17%), 28 which are a Buy (52.83%)

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

21

$0.11 (0.53%)

22

1 months ago

14/28 (50%)

$39.74 (43.74%)

142

Hold

22

$1.11 (5.31%)

80

1 months ago

5/12 (41.67%)

$15 (21.18%)

183

Hold

25

$4.11 (19.67%)

22

1 months 25 days ago

3/4 (75%)

$15.83 (31.14%)

107

Hold

24

$3.11 (14.89%)

25

3 months ago

5/10 (50%)

$13.18 (28.13%)

63

Hold

20

$-0.89 (-4.26%)

19

3 months 1 days ago

16/17 (94.12%)

$3.42 (7.81%)

81

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is SAGE (Sage Therapeutics) average time for price targets to be met?

On average it took 172.3 days on average for the stock forecasts to be realized with a an average price target met ratio 55.39

Which analyst has the current highest performing score on SAGE (Sage Therapeutics) with a proven track record?

PAUL MATTEIS

Which analyst has the most public recommendations on SAGE (Sage Therapeutics)?

Paul Matteis works at STIFEL and has 25 price targets and 21 ratings on SAGE

Which analyst is the currently most bullish on SAGE (Sage Therapeutics)?

Adam Walsh with highest potential upside - $220.6

Which analyst is the currently most reserved on SAGE (Sage Therapeutics)?

Vamil Divan with lowest potential downside - -$0.89

To continue looking at which analysts cover the stock please register to the basic or advanced membership

How to use the chart